"This is Donald Trump’s America. What you read on this

New Post Public Reply Private Reply Replies (2) Message Board

Apr 10, 2016 at 2:48 PM

Quote:

"This is Donald Trump’s America. What you read on this page is what might happen if the GOP frontrunner can put his ideas into practice, his words into action.

Boston Globe to publish fake front page on Trump presidency
By Hadas Gold

04/09/16 06:49 PM EDT

The Boston Globe on Sunday will publish a satirical front page predicting headlines about a Donald Trump presidency alongside a “Stop Trump” editorial.

The fake front page will be the lead of the Globe’s Sunday Ideas section and "is a work of political satire and commentary produced by the Globe's Editorial Board, not the newsroom,” Globe Editorial Page Editor Ellen Clegg wrote in an email. A PDF of the front page was published on Saturday afternoon.

The banner headline on the fake page, dated a year from Sunday, reads: “Deportations to begin, President Trump calls for tripling of ICE force; riots continue.” The page includes full, realistic articles about Trump’s actions as president.

The main story includes mentions of an Attorney General Chris Christie, and Fox News’ Megyn Kelly tweeting from a bar because she’s been placed on a White House black list.

Other stories on the fake front page include “U.S. soldiers refuse orders to kill ISIS families” and details such as new libel laws targeting “absolute scum” in the press.

Another story is about how Trump had offended the Chinese first lady by naming his new dog after her.

An editor’s note at the bottom of the page explains why the paper chose to create it.

"This is Donald Trump’s America. What you read on this page is what might happen if the GOP frontrunner can put his ideas into practice, his words into action. Many Americans might find this vision appealing, but the Globe’s editorial board finds it deeply troubling,” the editor’s note reads.

An editorial on the following page urges the GOP to stop Trump.

"The satirical front page of this section attempts to do just that, to envision what America looks like with Trump in the White House,” the editorial states. "It is an exercise in taking a man at his word. And his vision of America promises to be as appalling in real life as it is in black and white on the page.

It is a vision that demands an active and engaged opposition. It requires an opposition as focused on denying Trump the White House as the candidate is flippant and reckless about securing it."

The editorial goes on to note the controversy surrounding Trump, including his “winks and nods” to violence at his rallies.

"If Trump were a politician running such a campaign in a foreign country right now, the US State Department would probably be condemning him,” the editorial states.

The editorial ends with a warning that Sen. Ted Cruz, who is currently rallying Republicans behind him as the only candidate who could stop Trump from securing the GOP nomination, could be even more dangerous.

"If the party can muster the courage to reject its first-place finisher, rejecting the runner-up should be even easier,” the editorial states. "The Republican Party’s standard deserves to be hoisted by an honorable and decent man, like Romney or Ryan, elected on the convention floor. It is better to lose with principle than to accept a dangerous deal from a demagogue."

In an email, the Globe's Sunday Ideas Editor Katie Kingsbury said the goal was to start a conversation and get voters who haven't voted yet to have a clear view of the future.

"This is an exercise in taking Donald Trump at his word. We decided to report out the policy positions he's pledged, to fill in the details, and to play out his vision to its natural consequences.

Our goal is to create a conversation about what a Donald Trump presidency could look like and the vision he has for America's future," Kingsbury said in an email, noting that the popular sense of a Trump campaign unraveling is "wishful thinking."

"There is almost no way Ted Cruz arrives at the convention this summer with a majority of delegates. And there are still several major primaries on the horizon — New York, for one — where Trump has solid momentum. We want Americans still considering candidates going into the voting booths with a clear view of the presidency they are choosing," she said.

Read more: http://www.politico.com/blogs/on-media/2016/0...z45RzjlcH6

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

DigitalXForce Booms with 514% Growth and Major Backing

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Hims & Hers Faces Securities Lawsuit Amid Stock Dive

Hims & Hers Takes a Hit Right out of the gate, we're seeing Hims & Hers Health, Inc. (NYSE:HIMS) embroiled in a securities class action, thanks to some good old-fashioned alleged corporate shenanigans. It's one of those times where you'd cock an eyebrow and say, "What in the world were they thinking?" The FTC has slapped them with accusations of misleading privacy claims...

Bio-Thera's New Data: A Game Changer for NSCLC?

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Millrose Faces Securities Fraud Suit Amidst Decline

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

York Space Systems Class Action: Deadline Approaches

Rapid Deadline: October 30 Looms for York Space Systems You blink, and you might miss the deadline. We’re just a step away from deadline day in the York Space Systems’ class action lawsuit. If you've got skin in this game, time's not on your side. Shareholders, particularly those who hopped on the York Space train via their IPO back in January 2026, are staring down...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Swanson Nexus Pro Launch: Boost for Dietitians

By Lucas Young Updated Oct 24, 2026 Category News Views 134

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...